Swiss National Bank Has $1.77 Million Stock Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Swiss National Bank boosted its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 2.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 38,500 shares of the company’s stock after acquiring an additional 1,000 shares during the period. Swiss National Bank’s holdings in Establishment Labs were worth $1,774,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. Bamco Inc. NY lifted its stake in shares of Establishment Labs by 13.6% in the third quarter. Bamco Inc. NY now owns 489,386 shares of the company’s stock valued at $21,176,000 after buying an additional 58,611 shares in the last quarter. Assenagon Asset Management S.A. bought a new stake in Establishment Labs during the fourth quarter worth $12,898,000. Redmile Group LLC raised its position in Establishment Labs by 22.9% in the 3rd quarter. Redmile Group LLC now owns 261,803 shares of the company’s stock valued at $11,328,000 after buying an additional 48,779 shares during the last quarter. Raymond James Financial Inc. bought a new position in Establishment Labs during the 4th quarter valued at $5,494,000. Finally, Portolan Capital Management LLC purchased a new position in Establishment Labs during the 3rd quarter worth $2,446,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Stephens restated an “overweight” rating and issued a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $57.40.

Establishment Labs Price Performance

ESTA stock opened at $40.43 on Friday. The firm has a 50 day simple moving average of $36.36 and a two-hundred day simple moving average of $40.83. The stock has a market cap of $1.17 billion, a PE ratio of -15.67 and a beta of 0.95. Establishment Labs Holdings Inc. has a one year low of $28.16 and a one year high of $60.12. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $44.51 million for the quarter, compared to analysts’ expectations of $44.45 million. On average, analysts predict that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.